Display Settings:

Format

Send to:

Choose Destination
Atherosclerosis. 2013 Dec;231(2):218-22. doi: 10.1016/j.atherosclerosis.2013.09.007. Epub 2013 Sep 19.

APOE p.Leu167del mutation in familial hypercholesterolemia.

Author information

  • 1The Research Institute of the McGill University Health Centre, Faculty of Medicine, Royal Victoria Hospital, 687 Pine Avenue West, Montréal, QC H3A 1A1, Canada; Institut de Recherches Cliniques (IRCM) Affiliated to Université de Montréal, 110 Pine Avenue West, Montréal, QC, Canada.

Abstract

BACKGROUND:

Autosomal dominant hypercholesterolemia (ADH) is caused by mutations in the low density lipoprotein receptor (LDLR), its ligand apoB (APOB) or proprotein convertase subtilisin/kexin type 9 (PCSK9) genes. Yet DNA sequencing does not identify mutations in these genes in a significant number of cases, suggesting that ADH has multiple genetic etiologies.

METHODS:

Through a combination of clinical examination, biochemical analysis, candidate gene approach and next-generation exome sequencing we investigated the genetic basis of an ADH phenotype in a proband of an Italian origin.

RESULTS:

The proband presented with an acute myocardial infarction at age 43. He had tendinous xanthomas, xanthelasmas and elevated levels of total and LDL cholesterol, at 11.2 and 9.69 mmol/L, respectively, with normal levels of HDL cholesterol and triglycerides at 1.62 and 1.13 mmol/L, respectively. HPLC lipoprotein profile showed selective increase in LDL-C. DNA sequencing did not identify any mutation in the LDLR, PCSK9, LDLRAP1 and APOB gene. We then performed exome sequencing on three individuals from the family. The strongest evidence of association was found for the previously identified apolipoprotein E mutation (APOE, chromosome 19:45412053-55) known as APOE Leu167del, an in-frame three base-pair deletion. Computational biology confirmed the deleterious nature of this mutation. The Leu167del mutation is predicted to alter the protein structure of apoE near the α-helix within the receptor binding domain.

CONCLUSIONS:

This report confirms a previous report that ADH can be caused by mutations within the APOE gene and represents the 4th loci causing ADH. Standard screening for ADH should include APOE gene.

Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

KEYWORDS:

APOE gene; Autosomal dominant hypercholesterolemia; Familial hypercholesterolemia

PMID:
24267230
[PubMed - in process]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk